Dissecting OCM Performance Period 4 Results and Their Implications

September 25, 2019

With Oncology Care Model performance period 4 results out now, it’s a transformative point in the model in which practices that have not yet achieved a performance-based payment have to either enter 2-sided risk or leave the model. To dive into the most recent results and their implications, we spoke with Charles Saunders, MD, chief executive officer of Integra Connect.

Now 3 years into the Oncology Care Model, practices participating in the episode-based model have recently received results from performance period 4, representing care delivered in the first half of 2018. Results from the previous 2 performance periods have some practices concerned because there was little improvement; During both performance period 2 and 3 approximately 30% of practices achieved savings.

With performance period 4 results out now, it’s a transformative point in the model in which practices that have not yet achieved a performance-based payment have to either enter 2-sided risk or leave the model. To dive into the most recent results and their implications, we spoke with Charles Saunders, MD, chief executive officer of Integra Connect.

iTunes

TuneIn

Stitcher

Spotify

Read more about the Oncology Care Model performance period results:

Lessons From the Field: How Practices Are Succeeding Under OCM

Mike Fazio: Practices Are Happier With PP4 Results in the OCM

COA Submits OCM 2.0 Proposal

COA Urges Delay in Downside Risk Deadline for OCM

Listen above or through one of these podcast services: